| 2012 - 2016 | Priority Setting in Global Health - 2020 | Ole Frithjof Norheim |
| 2012 - 2012 | Medication use in pregnancy with focus on attitudes, perception of risk and mental well-being | Hedvig Nordeng |
| 2012 - 2014 | Characterisation of human exposure pathways to novel flame retardants | Cathrine Thomsen |
| 2012 - 2014 | Toppfinansiering - Nilsbo - Cornelis Borgesius | Ayumu Tashiro |
| 2012 - 2014 | Development of biodegradable nanobeads as vaccines against tuberculosis. | Gareth Griffiths |
| 2011 - 2014 | Treatment of Non-Hodgkin Lymphoma with 177Lu-HH1/Betalutin | Jostein Dahle |
| 2011 - 2013 | Forskerprosjekt | Zuhal Skaar-Olsen |
| 2010 - 2014 | Vaccine development in Orientia tsutsugamushi infection | Pål Aukrust |
| 2010 - 2014 | Advancing Rotavirus Vaccine Development (ARVAC) - BBIL Phase 3 Study | John Boslego |
| 2010 - 2012 | 'Communicate to vaccinate': Building evidence for improving communication about childhood vaccinations in low- and middle-income | Simon Lewin |
| 2010 - 2013 | Vaccibodies for SIV: a step towards an HIV vaccine for humans. | Inger Øynebråten |
| 2010 - 2013 | Novel vaccine candidates against meningococcal disease | Tone Tønjum |
| 2010 - 2014 | Molecular control of T cell memory | Anne Spurkland |
| 2010 - 2013 | Health systems strengthening within vaccination programmes: an ethnographic study (HEALVAC) | Sidsel Roalkvam |
| 2010 - 2013 | To what extent do user fees affect Hepatitis B vaccine coverage rates in China? | Knut Reidar Wangen |
| 2010 - 2015 | Target cell recognition by natural killer cells | Erik Dissen |
| 2010 - 2013 | mVAC - Mobile innovations in recording child vaccination and health data in immunization registers | Thorkild Tylleskær |
| 2010 - 2013 | Development of a food-grade Lactobacillus-based oral vaccine delivery system | Vincent Eijsink |
| 2010 - 2013 | Studies of humoral and cell-mediated protective immune markers during Mycobacterium tuberculosis infection in human population | Gunnar Aksel Bjune |
| 2010 - 2013 | Biomarkers of mycobacterial infection and disease, and molecular characterization of mycobacteria from high TB-burden countries. | Ruth Stavrum |
| 2010 - 2012 | Additional activities related to an ongoing project: Impact of the new vaccine MenAfriVac on carriage of serogroup A Neisseria m | Dominique A. Caugant |
| 2009 - 2009 | Abdul, Shabbir Syed. Indisk spesialist 2009 | Shabbir Syed Abdul |
| 2009 - 2010 | Development of a proposal on Norwegian engagement and collaborative projects in a phase III trial of oral rotavirus vaccine ORV | Tor Arne Strand |
| 2008 - 2009 | Hovedrapport fra evalueringen av Opptrappingsplanen for psykisk helse | Karl Erik Brofoss |
| 2008 - 2008 | Suetterlin, Stefan, GB, statsstip 2008-09 | Stefan Suetterlin |
| 2008 - 2011 | EXERCISE IN MEDICINE: BIO-EPIDEMIOLOGY OF FITNESS AND CARDIOVASCULAR DISEASE | Ulrik Wisløff |
| 2007 - 2013 | Lipocalin 2 - a novel antimicrobial protein: Role in mycobacterial disease, urinary tract infection and in wound healing | Trude Helen Flo |
| 2007 - 2010 | Nutritional intervention and novel diagnostics to improve community-based control of tuberculosis | Harleen Grewal |
| 2007 - 2010 | Characterization of the Mycobacterium tuberculosis phosphorylome and its role in pathogenesis | Harald G. Wiker |
| 2007 - 2013 | Immunity towards mycobacteria - identification of avirulent vaccine strains and therapeutic targets | Trude Helen Flo |
